Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2.
Sparano
J A
JA
Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, New York.
Brandt
L J
LJ
Dutcher
J P
JP
DuBois
J S
JS
Atkins
M B
MB
D000368:Aged; D002292:Carcinoma, Renal Cell / Q000150:complications / Q000188:drug therapy* / Q000556:secondary; D003424:Crohn Disease / Q000150:complications / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D007376:Interleukin-2